Patent SG-11201909689T-A (SG)
Title: Method and system for monitoring a diabetes treatment plan
Inventor: CHAN SIDNEY SOONG-LING
IPC: G06Q50/22
Filed: 2017-06-20
Abstract: WO 18/ 23 2487 Al -Time Intervals for Ile, Measured A1c — Terse 1115 - Blood Glucose ON• -Model—Formulas and Time Int. 127 to evaluate predicted Plc 125 Apply BFM and adjustment factor to calculate predicted FI G.2 Upload New Measured Alc Upload New Blood Glucose Data Ouput re;cted Alc ' pee. 111 Obtain plurality of BGavE valu„ 1E1 Glucose data 131 Don pred15350 Output predicted alc excestl555551ation and escalelon alert to threshok13 ontli1.5511555 U5 I/155015E5d 5111314:5151 (BM) by selectlng 5155151with lawn ever.\" varlance between cal51.551 AU memund1115 123 Calculate accordingto eFM Determine adjustment factor for BFM (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date 27 December 2018 (27.12.2018) WIP0 I PCT omit VIII °nolo III minim IH mo Imo oimIE (10) International Publication Number WO 2018/232487 Al (51) International Patent Classification: GO6Q 50/22 (2018.01) GOOF 19/00 (2018.01) G16H 20/00 (2018.01) G16H 10/60 (2018.01) A61B 90/00 (2016.01) A61B 5/145 (2006.01) (21) International Application Number: PCT/CA2017/050753 (22) International Filing Date: 20 June 2017 (20.06.2017) (25) Filing Language: English (26) Publication Language: English (72) Inventor; and (71) Applicant: CHAN, Sidney Soong-Ling [CA/SG]; 33-01, 53 Cairnhill Road, Singapore 229664 (SG). (74) Agent: EDWARDS, Antony C.; 400-444 7 Avenue SW, Calgary, Alberta T2P0X8 (CA). (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG). Declarations under Rule 4.17: as to applicant's entitlement to apply for and be granted a patent (Rule 4.17(ii)) of inventorship (Rule 4.17(iv)) Published: — with international search report (Art. 21(3)) (54) Title: METHOD AND SYSTEM FOR MONITORING A DIABETES TREATMENT PLAN (57) : A method and system for monitoring the effectiveness of a patient's diabetes treatment plan by predicting, on a frequent basis, the patient's glycated hemoglobin (Alc) based on the patient's blood glucose (BG) may include applying a plurality of Alc models to a BG data set of the patient so as to obtain a plurality of calculated Alc values and identifying a best fit model amongst the plurality of Alc models by evaluating the plurality of calculated Alc values against at least one measured Alc value; calculating a predicted Alc value by applying the identified best fit model to the BG da- ta set. Some embodiments may further include evaluating the predicted Alc value against a set of escalation rules to determine whether an escalation alert is required; alerting the patient's healthcare provider when it is determined the escalation alert is required; and outputting the predicted Alc value to the patient.